Restarting a GLP-1 After a Break: Do You Re-Titrate?

Life interrupts a GLP-1 for all kinds of reasons: a supply gap, a pause between prescriptions, a planned break, or forgetting for a stretch. When you go to pick it back up, the practical question is whether you can resume the dose you were on or whether you have to start low and climb again. The honest answer depends almost entirely on how long the gap was. This piece walks through what the drug labels say, where they stay silent, and how to think about restarting safely.

Before anything else: this is a decision to make with the clinician who prescribed your medication, not a rule to apply on your own. If you want to see how a restart maps onto real calendar dates, you can rebuild your dosing timeline with our GLP-1 titration schedule calculator once you and your prescriber have settled on a plan.

Why a short gap is different from a long one

The key fact behind all of this is how long these drugs linger in your body. Semaglutide (Ozempic, Wegovy) has a half-life of about one week, and tirzepatide (Mounjaro, Zepbound) about five days. Because it takes roughly five half-lives for a drug to clear, a single missed weekly injection still leaves a large fraction of the last dose working, and full washout takes around five weeks for semaglutide.

That long tail is why a missed week is not the same as a fresh start. If the drug is still substantially present in your system, your gut has not “reset,” and resuming your usual dose is usually straightforward. Once the gap stretches long enough that the drug has mostly cleared, your tolerance to it fades, and that is when restarting at your old dose can bring back the nausea and GI upset you had already moved past.

After a short gap of a week or two, most people resume their usual dose; semaglutide and tirzepatide both stay active in the body for weeks.

What the labels say about missed doses

The prescribing information for each drug gives a specific window for a single missed dose:

Drug	Missed-dose window	If the window has passed
Semaglutide (Ozempic)	Take within 5 days	Skip it; resume on the regular day
Semaglutide (Wegovy)	Take if the next dose is more than 48 hours away	Skip it; resume on the regular day
Tirzepatide (Zepbound/Mounjaro)	Take within 4 days (96 hours)	Skip it; resume on the regular day

These windows cover one missed injection, not a multi-week pause. For a genuine break, the most useful label language comes from Wegovy, which addresses multiple consecutive missed doses directly: resume dosing as scheduled, or “if needed, reinitiate WEGOVY and follow the dose-escalation schedule.” In plain terms, the label itself acknowledges that after enough missed doses you may need to start the ramp over.

The gray zone: when does a break become a restart?

Here is the part worth being honest about: there is no crisp, universal number of weeks at which a pause officially becomes a restart. The Wegovy label uses “if needed” precisely because the answer is individual. It depends on how long you were off, what dose you were on, how well you tolerated it originally, and how your body responds.

A reasonable way to think about it, consistent with how these drugs behave:

• A gap of about one to two weeks. The drug is still substantially present. Most people resume their usual dose, subject to their prescriber’s guidance.
• A gap of several weeks or more. The drug has mostly cleared and gut tolerance has faded. This is where re-titrating from a lower step, often the starting dose or one step below where you left off, becomes the safer approach.

Because the labels don’t draw a hard line, the exact threshold is a clinical judgment call. The longer and higher the dose you were on, and the longer the gap, the more the balance tips toward re-titrating. We go deeper into what happens to appetite, weight, and side-effect sensitivity when you come off these drugs in our companion piece on what happens when you stop a GLP-1.

Why re-titrating is the cautious default

The reason to restart low is the same reason you titrated slowly the first time. GLP-1 side effects (nausea, reduced appetite, constipation, sometimes vomiting or diarrhea) are dose-related, and they are worst right after any jump in dose. When you first started, your gut adapted gradually over the fixed escalation steps. After a long enough break, that adaptation partly unwinds, so jumping straight back to a high maintenance dose can feel like starting over at the deep end.

Re-titrating trades a little time for a lot more comfort. You may move through the early steps faster than a true first-timer if your body remembers the drug, but starting below your previous dose gives your gut a cushion. The full logic behind stepwise dosing, and why rushing it tends to backfire, is laid out in our explainer on why slow titration wins.

A practical checklist for restarting

None of this replaces your prescriber, but these are the questions that shape the plan:

• How long has it been since your last dose? Count from the injection date, not from when your prescription lapsed.
• What dose were you on, and did you tolerate it well? A high dose after a long gap is the classic setup for a rough restart.
• Do you still have the right pen strength? Restarting lower may mean a different pen or dose setting than the one you finished on.
• Has anything else changed? New medications, pregnancy plans, or other health changes can all affect the plan and are worth flagging.

The takeaway

Whether you re-titrate after a GLP-1 break comes down to time. A short pause of a week or two usually means resuming your normal dose, because the drug is still on board. A longer break tips toward restarting at a lower step and climbing again, because your gut’s tolerance fades as the drug clears, and the labels explicitly leave room for exactly that. There is no official cut-off that turns a pause into a restart, which is precisely why the call belongs to you and your prescriber rather than a chart.

This is educational information, not medical advice. Talk to the clinician who prescribed your medication before changing anything. When you have a plan, map your restart on our GLP-1 titration schedule calculator, and for the full picture on dosing these drugs, see our complete GLP-1 guide.

Sources

• Wegovy (semaglutide) Dosing and Administration — NovoMedLink (Novo Nordisk)
• Ozempic (semaglutide) Pen Dosing — Novo Nordisk
• Zepbound (tirzepatide) HCP Dosage — Lilly
• Semaglutide (~1-week half-life) and tirzepatide (~5-day half-life) pharmacokinetics: FDA prescribing information for Ozempic, Wegovy, and Zepbound.